Kumar Haldea Revocable Trust U/A DTD 12/19/2018, Director, Officer: BridgeBio Pharma BBIO Planned sale · Filed 25/02/19

Trade details

Type: Planned sale notice
Stock: BridgeBio Pharma BBIO
Person: Kumar Haldea Revocable Trust U/A DTD 12/19/2018Director, Officer
Planned sale date: 25/02/19
Filed: 25/02/19

More to sell after $21.8M in 3 months

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 25/01/20~25/03/21

Kumar Haldea Revocable Trust U/A DTD 12/19/2018's recent trades

Neil KumarDirector, Officer
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$2.5M
30,000 sh
$2.5M
Filed 08/19
Traded 08/19
Neil KumarDirector, Officer
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$2.8M
34,980 sh
$2.8M
Filed 08/18
Traded 08/18
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$1.1M
15,921 sh
$1.1M
Filed 06/08
Traded 06/04
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$1.1M
15,921 sh
$1.1M
Filed 06/08
Traded 06/04
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$572.7K
8,437 sh
$572.7K
Filed 06/08
Traded 06/05